🔗 Permalink

Inventor profile of:

Thomas E. Wagner

City:

Greenville, South Carolina

Country:

United States

Published Applications:

Last publication date:

2025-08-21

Top Assignees for applications by Thomas E. Wagner

The entities that hold a legal rights for patent applications filed by inventor Wagner Thomas E.:

Orbis Health Solutions LLC 21 Greenville, SC United States
Thomas E. Wagner 2 Greenville, SC United States
Greenville Hospital System 1 Greenville, SC United States
Elios Holdings, LLC 1 Austin, TX United States

Recent patent applications by Wagner Thomas E.

Thomas E. Wagner from Greenville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-21

US20250264386A1

Physics

METHODS AND DEVICES FROM ISOLATION OF TUMOR CELLS

#2 | 2025-01-09

US20250009875A1

Human necessities

VACCINES FOR IN VIVO EXPRESSION OF NUCLEIC ACIDS AND METHODS OF USING THE SAME

#3 | 2024-10-24

US20240350540A1

Human necessities

TUMOR LYSATE LOADED PARTICLES

#4 | 2023-11-02

US20230346904A1

Human necessities

BACTERIAL AND VIRAL VACCINE STRATEGY

#5 | 2022-05-26

US20220162644A1

Chemistry; metallurgy

DELIVERY VECTORS AND PARTICLES FOR EXPRESSING CHIMERIC RECEPTORS AND METHODS OF USING THE SAME

#6 | 2022-05-19

US20220151943A1

Human necessities

Vaccine delivery systems using yeast cell wall particles

#7 | 2021-12-23

US20210393771A1

Human necessities

Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same

#8 | 2021-08-19

US20210252052A1

Human necessities

TUMOR LYSATE LOADED PARTICLES

#9 | 2020-11-26

US20200368172A1

Human necessities

Vaccine delivery systems using yeast cell wall particles

#10 | 2020-03-05

US20200069596A1

Human necessities

Vaccine delivery systems using yeast cell wall particles

#11 | 2019-08-08

US20190240162A1

Human necessities

Vaccine delivery systems using yeast cell wall particles

#12 | 2018-12-27

US20180371494A1

Chemistry; metallurgy

T7 alpha viral vector system

#13 | 2018-08-16

US20180228885A1

Human necessities

BACTERIAL AND VIRAL VACCINE STRATEGY

#14 | 2018-08-02

US20180214484A1

Human necessities

Tumor lysate loaded particles

#15 | 2017-11-09

US20170319620A1

Human necessities

Tumor lysate loaded particles

#16 | 2017-03-09

US20170065532A1

Human necessities

Vaccine delivery systems using yeast cell wall particles

#17 | 2017-01-12

US20170007688A1

Human necessities

VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES

#18 | 2015-08-13

US20150224126A1

Human necessities

Compositions and methods for tissue regeneration

#19 | 2014-09-04

US20140248316A1

Human necessities

HYBRID CELLS FOR TREATING CANCER PATIENTS

#20 | 2014-06-12

US20140161912A1

Human necessities

Compositions and methods for tissue regeneration

#21 | 2014-03-06

US20140065190A1

Human necessities

Tumor lysate loaded particles

#22 | 2014-03-06

US20140065173A1

Chemistry; metallurgy

TUMOR LYSATE LOADED PARTICLES

#23 | 2013-05-23

US20130131640A1

Chemistry; metallurgy

METHOD OF CREATING AND SORTING FUSED CELLS

#24 | 2010-11-11

US20100284975A1

Chemistry; metallurgy

Polypeptides comprising Fas activation and NKG2D-ligand domains

#25 | 2010-05-06

US20100111985A1

Human necessities

VACCINE COMPOSITIONS AND METHODS OF USE

#26 | 2009-05-07

US20090117658A1

Human necessities

Macrophage transfection method

#27 | 2009-03-26

US20090081789A1

Chemistry; metallurgy

Activation of nuclear factor kappa B

#28 | 2008-10-02

US20080242610A1

Chemistry; metallurgy

Polypeptides comprising Fas activation and NKG2D-ligand domains

#29 | 2008-04-17

US20080090752A1

Human necessities

Anti-tumor vasculature effects of human serum albumin derivatives

#30 | 2005-04-05

US10112036

Monocyte-specific particulate delivery vehicle

#31 | 2005-02-03

US20050025771A1

Chemistry; metallurgy

Antitumor agents comprising a targeting portion and an immune response triggering portion

#32 | 2005-01-13

US20050009740A1

Human necessities

Anti-tumor vasculature effects of human serum albumin derivatives

InventorID:

265184 ⎘